National Comprehensive Cancer Network

About NCCN

Upcoming NCCN Breast Cancer Congress to Feature Updates from 2015 San Antonio Breast Cancer Symposium

Breast cancer is the most common malignancy in women in the United States and is second only to lung cancer as a cause of cancer death. The clinical evaluation and therapeutic options for people with non-invasive and invasive breast cancer are complex and varied. Health care professionals require education on current and emerging scientific data to make evidence-based decision and to provide optimal care for patients with breast cancer.

Moreover, as the complexity and important of screening, testing, and individualized treatment strategies for breast cancer have increased, so has clinicians’ reliance on NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) for Breast Cancer, as well as NCCN educational interventions, to increase knowledge and bridge the gaps between knowledge and competence.

The NCCN 2016 Congress Series™: Breast Cancer, hosted on Friday, February 12, 2016, by Robert H. Lurie Comprehensive Cancer Center of Northwestern University in Chicago, will present a comprehensive summary of the most up-to-date research and clinical data presented at the 2015 San Antonio Breast Cancer Symposium.

“Health care providers caring for patients with breast cancer are increasingly challenged by new developments in disease management,” said William J. Gradishar, MD, Chair of the NCCN Guidelines Panel for Breast Cancer, and Betsy Bramsen Professor of Breast Oncology, Professor of Medicine, and Director of the Maggie Daley Center for Women’s Cancer Care, Robert H. Lurie Comprehensive Cancer Center of Northwestern University. “The optimal treatment of breast cancer is becoming increasingly complex, requiring an understanding of the biology of the disease, which, in turn, can inform treatment recommendations both locally and systemically.”

The 2016 Breast Cancer Congress, which will take place from 8:30 AM to 3:30 PM CT, will feature expert discussion on ductile carcinoma in situ, adjuvant therapy and surgical management in treatment of early-stage breast cancer, the role of multigene assays in management of early-stage breast cancer, late-stage breast cancer, and fertility preservation, as well as updates from the San Antonio Breast Cancer Symposium on local, adjuvant, and neoadjuvant therapies.

To view the full agenda or to register for the Congress, visit